High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 9, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-30
DOI
10.1038/s41419-018-0903-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma
- (2018) Madhuchhanda Roy et al. HUMAN PATHOLOGY
- High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance
- (2018) In-geun Ryoo et al. Redox Biology
- Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres
- (2016) In-geun Ryoo et al. Biomolecules & Therapeutics
- p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
- (2016) Atsushi Umemura et al. CANCER CELL
- Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
- (2016) Jan S. Moreb et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines
- (2016) Radosſaw Januchowski et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition
- (2016) Safeena Kulsum et al. MOLECULAR CARCINOGENESIS
- p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA
- (2016) L-Z Xu et al. ONCOGENE
- All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells
- (2015) Ming-Jer Young et al. CARCINOGENESIS
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?
- (2014) Tongde Wu et al. MOLECULAR CARCINOGENESIS
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- Autophagy in stem cells
- (2013) Jun-Lin Guan et al. Autophagy
- Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells
- (2013) Shaobin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
- (2013) C. Le Magnen et al. CLINICAL CANCER RESEARCH
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- The secretome of colon cancer stem cells contains drug-metabolizing enzymes
- (2013) Benjamin L Emmink et al. Journal of Proteomics
- Prognostic Value of Cancer Stem Cell Marker Aldehyde Dehydrogenase in Ovarian Cancer: A Meta-Analysis
- (2013) Shuyan Liu et al. PLoS One
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Sestrins Activate Nrf2 by Promoting p62-Dependent Autophagic Degradation of Keap1 and Prevent Oxidative Liver Damage
- (2012) Soo Han Bae et al. Cell Metabolism
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
- (2012) Surendra Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells
- (2012) HONG-QUAN DUONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment
- (2012) Vanessa Rausch et al. JOURNAL OF PATHOLOGY
- Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
- (2012) R. Rao et al. MOLECULAR CANCER THERAPEUTICS
- The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells
- (2012) S Galavotti et al. ONCOGENE
- Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells
- (2012) C Gong et al. ONCOGENE
- The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells
- (2011) Jenny M. Whitworth et al. GYNECOLOGIC ONCOLOGY
- Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species
- (2011) Santhi Achuthan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition
- (2011) M Ying et al. ONCOGENE
- High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
- (2010) Christel van den Hoogen et al. CANCER RESEARCH
- Stem cells in cancer: instigators and propagators?
- (2010) M. R. Alison et al. JOURNAL OF CELL SCIENCE
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
- (2010) A. Lau et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
- (2010) Masaaki Komatsu et al. NATURE CELL BIOLOGY
- Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway
- (2009) Gi-seong Shim et al. FREE RADICAL BIOLOGY AND MEDICINE
- ALDH1 expression correlates with favorable prognosis in ovarian cancers
- (2009) Bin Chang et al. MODERN PATHOLOGY
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
- (2009) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search